Rigel Pharmaceuticals Newsroom

Rigel Pharmaceuticals Analyst Ratings

BenzingaNov 12 13:34 ET

Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $49

Moomoo NewsNov 11 15:32 ET

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsNov 8 07:35 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaOct 25 06:57 ET

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsOct 25 06:31 ET

Rigel Pharmaceuticals Price Target Maintained With a $15.00/Share by Cantor Fitzgerald

Dow JonesSep 20 12:40 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaSep 5 14:38 ET

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsSep 3 10:32 ET

HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Adjusts Price Target To $57 (1-20 Reverse Stock Split)

BenzingaAug 9 17:47 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaAug 9 17:45 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 25 07:22 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 17 06:20 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 3 12:34 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaMay 8 09:38 ET

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

BenzingaMay 8 09:38 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaMar 7 11:01 ET

Citigroup Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $4

BenzingaMar 7 09:30 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaMar 6 08:38 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaFeb 22 12:25 ET

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

BenzingaJan 4 10:27 ET